Literature DB >> 1688177

Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome.

H Schneid1, M P Vazquez, D Seurin, Y le Bouc.   

Abstract

The Insulin-like growth factor II (IGF-II) gene has been analysed by Southern blotting in healthy and tumor tissue in two children with Beckwith-Wiedemann syndrome, using the enzymes, AvaII and SacI. Loss of heterozygosity was determined not only in the DNA of a nephroblastoma, but also in the healthy kidney, leukocytes and fragments of tongue removed for obstructive macroglossia. Allele loss therefore seems to be sufficient to provoke tumorigenesis in some tissues, but not in others.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1688177

Source DB:  PubMed          Journal:  Growth Regul        ISSN: 0956-523X


  5 in total

1.  Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome.

Authors:  H Schneid; D Seurin; M P Vazquez; M Gourmelen; S Cabrol; Y Le Bouc
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

2.  IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma.

Authors:  F Hedborg; R Ohlsson; B Sandstedt; L Grimelius; J C Hoehner; S Pählman
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.

Authors:  F Hedborg; L Holmgren; B Sandstedt; R Ohlsson
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

4.  The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Jessica R Griff; Riccardo Fagiano; Jonida Kupa; Garrett M Brodeur; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-04       Impact factor: 4.553

Review 5.  The yin and yang of kidney development and Wilms' tumors.

Authors:  Peter Hohenstein; Kathy Pritchard-Jones; Jocelyn Charlton
Journal:  Genes Dev       Date:  2015-03-01       Impact factor: 11.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.